AbbVie
ABBV
#26
Rank
โ‚ฌ332.02 B
Marketcap
187,86ย โ‚ฌ
Share price
1.17%
Change (1 day)
3.07%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ13.64 M-84.26%
2025โ‚ฌ86.68 M-56.05%
2024โ‚ฌ0.19 B-13.93%
2023โ‚ฌ0.22 B-63.52%
2022โ‚ฌ0.62 B629.28%
2021โ‚ฌ86.13 M-77.97%
2020โ‚ฌ0.39 B85.64%
2019โ‚ฌ0.21 B-52.97%
2018โ‚ฌ0.44 B269.88%
2017โ‚ฌ0.12 B-48.45%
2016โ‚ฌ0.23 B-37.53%
2015โ‚ฌ0.37 B-44.13%
2014โ‚ฌ0.67 B2387.79%
2013โ‚ฌ27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
โ‚ฌ56.21 Mโ‚ฌ0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ0.20 Bโ‚ฌ0.41 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ0.20 Bโ‚ฌ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.4 Mโ‚ฌ75.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.58 Mโ‚ฌ0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ31.05 Mโ‚ฌ81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ99.41 Mโ‚ฌ0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ48.95 Mโ‚ฌ0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ5.02 Mโ‚ฌ30.19 M๐Ÿ‡บ๐Ÿ‡ธ USA